12 weeks, 342 patients: the MELA B3 serum results revealed

Bringing together science, expertise and collaboration.

We were delighted to welcome dermatologists and healthcare professionals to the La Roche-Posay MELA B3 scientific event, where we had the opportunity to share the findings of the Mauritian observational study led by Dr Conhyea, exchange ideas and connect with peers who are equally passionate about improving patient care.

Thank you to everyone who joined us and helped make this event such a meaningful exchange of knowledge and expertise. Together, we remain committed to advancing scientific knowledge and supporting the effective management of pigmentary disorders in Mauritius through evidence-based skincare solutions.

Back to Blog

Read also

HealthActiv news

2026, July 08

Maurice franchit une nouvelle étape dans la prise en charge des troubles du rythme cardiaque avec le premier pacemaker sans sonde Abbott

Healthcare

2026, June 09

Quand l’horloge interne s’emballe : rythme circadien et hypertension

HealthActiv news

2026, June 03

A New Era for Cardiac Care in Mauritius: Launch of the First Public-Sector Electrophysiology Programme

Healthcare

2026, May 17

High blood pressure: The silent killer